Pyrimidine derivatives for the treatment op GABA B mediated nervous system disorders

Details for Australian Patent Application No. 2006261122 (hide)

Owner Novartis AG

Inventors Floersheim, Philipp; Froestl, Wolfgang; Kaupmann, Klemens; Guery, Sebastien; Koller, Manuel

Agent Davies Collison Cave

Pub. Number AU-A-2006261122

PCT Pub. Number WO2006/136442

Priority 0512844.2 23.06.05 GB

Filing date 23 June 2006

Wipo publication date 28 December 2006

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07F 7/02 (2006.01) Compounds containing elements of the 4th Group of the Periodic System

C07F 7/08 (2006.01) Compounds containing elements of the 4th Group of the Periodic System

C07F 9/02 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6512 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/136442 Priority application(s): WO2006/136442

10 April 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Pyrimide derivatives for the treatment of GABA B mediated nervous system disorders

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261127-ILT3 binding molecules and uses therefor

2006261108-Method and composition to treat skin ulcers